JAY RAINS: Open Payments
NPI 1043718331 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,303 in 45 payments from 18 companies in 2025. Trend: 2023 $1,041 · 2024 $1,225 · 2025 $1,303
Food & beverage: $1,105Education: $198
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $285 |
| Astellas Pharma US Inc | 5 | $203 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $166 |
| ABBVIE INC. | 5 | $104 |
| Endo USA, Inc. | 4 | $88 |
| Sumitomo Pharma America, Inc. | 3 | $73 |
| Dendreon Pharmaceuticals LLC | 2 | $65 |
| Ferring Pharmaceuticals Inc. | 3 | $61 |
| Boston Scientific Corporation | 2 | $53 |
| Verity Pharmaceuticals Inc. | 2 | $40 |
Products named: ERLEADA, Nubeqa, BOTOX, Xtandi, XIAFLEX, RYBREVANT, ORGOVYX, PROVENGE.
Industry payments across GA — which companies pay providers there.
